Navigation Links
Genetic mystery behind muscle development unraveled.

New genes such as microRNAs (miRNAs) belong to the newly discovered group of genes. Researchers working at the University of North Carolina have discovered two genes // belonging to the microRNA group. These genes function was later attributed to the proper development of muscles in the organism.

The microRNAs were initially discovered (1993) in the genome of the worms. The genes have been fully studied and worked on by researchers to completely understand the functioning of these genes. It was then understood that they play a very important role as gene regulators in both multicellular organisms and humans.

"Our interest is in understanding, at the level of gene expression, how muscle cells develop. As microRNAs are gaining acceptance as global regulators of gene expression, we questioned whether they could be involved in the development of muscle," said Dr. Da-Zhi Wang, the senior and corresponding author of the study.

Muscle tissue is generated when myoblasts, or pre-muscle cells, stop proliferating and instead undergo irreversible changes (differentiation) that cause them to become myotubes, or mature muscle cells. The researchers studied two miRNAs – miR-1 and miR-133 – found exclusively in muscle cells. Because their genes are located so close to one another, miR-1 and miR-133 are always expressed together, yet they carry out opposing tasks.

The two miRNAs described in the UNC study are instrumental in determining if myoblasts proliferate or differentiate. The research showed that increasing the amount of miR-1 caused myoblasts to differentiate into mature muscle cells, but prevented their proliferation. To the contrary, increasing the amount of miR-133 caused the myoblasts to proliferate even more, but prevented them from undergoing differentiation.

Similar experiments carried out in developing frog embryos confirmed their finding. Increasing miR-1 caused more muscle tissue overall and fewer my
'"/>




Page: 1 2

Related medicine news :

1. Genetic Dentistry: Your Dentist may be able to grow you a new set of Teeth.
2. Genetic influence in menopause
3. Genetics and cholesterol levels
4. Genetics helps in attacking cancer
5. Genetic disorder related with sleep patterns
6. Genetic innovation
7. Genetic tests for cancer
8. Genetic indicates memory
9. Genetic mutation to the fountain of youth discovered
10. Genetic differences found between Male and Female brains
11. Alcoholism Influenced By Both Genetics & Family Environment
Post Your Comments:
(Date:5/20/2008)...e/ -- Ambulatory Services of,America, Inc. announc...h,joint venture to provide outpatient radiation on... between Denton Cancer Center, LP and ASA,s,subsid... ROSA of Denton,will own and operate a radiation t...ly owned and operated by Denton Cancer Center., (...
(Date:5/20/2008)...ng new out-patient procedures at no ... Calif., May 20 /PRNewswire/ -- Compass Clinical R... San Francisco Bay Area (RSC) are,hoping to recrui...nx, a,build-up of fluid in the fallopian tubes tha... as a part of a study of the effectiveness of a ne...
(Date:5/20/2008)...turated Fat - and with Omega-3, PARAMUS, N.J., Ma...(Nasdaq: SMBL ) has launched Smart Balance(R) But...utter Blend Sticks are 50 percent real butter,and ...art Balance(R) Butter,Blend Sticks are offered in ...or a healthier and tasty alternative for use in co...
(Date:5/20/2008)...ery or survival, researchers say. , , T...y dialysis for patients with acute kidney injury d...reduce the rate of organ failure, a new study find...n seen in critically ill patients. Approximately 2...d 35 percent of critically ill patients, will suff...
Breaking Medicine News(10 mins):Health News:Ambulatory Services of America, Inc. Announces Joint Venture With Denton Cancer Center, LP 2Health News:Research Grant to Fund Free Surgeries for Women Suffering From Blocked Fallopian Tubes 2Health News:Research Grant to Fund Free Surgeries for Women Suffering From Blocked Fallopian Tubes 3Health News:New Smart Balance(R) Butter Blend Sticks Make Healthier Cooking & Baking Easy 2Health News:More Dialysis Not Better in Acute Kidney Injury 2
...es produced by the hypothalamus, the area of the b... and body temperature, may underlie chronic migrai... the general population who suffer from the debili... hormones could prevent or reduce the severity of ...
...inistration has approved a new drug for treating o...erioration in the cartilage of certain joints. Unl...toimmune disease, osteoarthritis results from over...of strenuous sports, obesity or aging. Pharmacia C...
...e Warren Grant Magnuson Clinical Center shows that...cook" tumors without actually removing them. The n...y and liver cancers, can also be used on cancers e... radiofrequency ablation (RFA), a tiny needle is i...
...ferred the launch of 'Disprin CV' (cardiovascular)...painkiller 'Disprin Plus', the company's Regional ... announced a change in the brand-name 'Disprin Plu...unch of Disprin Plus, there were reports citing in...
Other Medicine News:
(Date:5/19/2008)...cs present preliminary Phase II data for the...d mechanically-ventilated patie...Call/ -- Bayer HealthCare,together with Nektar The...ve,preliminary Phase II data on their unique drug-... Thoracic Society (ATS) annual meeting. Amikacin,I...
(Date:5/19/2008)...Replacement Structurally Similar to, Native Bladde...iefing and Poster Sess... /- Tengion,Inc., a clinical stage b...,neo-organs and neo-vessels, presented preclinical...ment(TM) at the Annual Meeting of the American,Uro...
(Date:5/19/2008)...e 2008 Annual European Congress of, Rheumatology O... (EULAR) -, - Initiation of Phase 1 Human Study o... 2008 -, SAN DIEGO, May 19 /PRNe...aq: RDEA ) today announced the identification of ...f patients with gout, RDEA594. Gout is a,painful a...
(Date:5/19/2008)...t Scientists Refused To Do,Illustrates Vaccine Pro...TLANTA, May 19 /PRNewswire-USNewswire/ -- Findings...vaccines officially recommended by the CDC,and the...tism-like,symptoms. Lead investigator Laura Hewits...presented study results at the International Meeti...
Breaking Medicine Technology:Amikacin Inhale Shows Promising Results in Phase II Study 2Amikacin Inhale Shows Promising Results in Phase II Study 3Amikacin Inhale Shows Promising Results in Phase II Study 4Amikacin Inhale Shows Promising Results in Phase II Study 5Amikacin Inhale Shows Promising Results in Phase II Study 6Amikacin Inhale Shows Promising Results in Phase II Study 7Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM) 2Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 2Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 3Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 4Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 5Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists 2Fossil record supports evidence of impending mass extinction 935 1Fossil record supports evidence of impending mass extinction 935 2Yale chemist receives NIH Young Investigator Award for antibody targeting 934 1Yale chemist receives NIH Young Investigator Award for antibody targeting 934 2Yale chemist receives NIH Young Investigator Award for antibody targeting 934 3The Salvation Army Responds to Immediate Needs of Survivors and Relief Workers in Southern California Wildfires 4443 1The Salvation Army Responds to Immediate Needs of Survivors and Relief Workers in Southern California Wildfires 4443 2The Salvation Army Responds to Immediate Needs of Survivors and Relief Workers in Southern California Wildfires 4443 3ACC Concerned Over Reporting of Biomonitoring Results 625 1ACC Concerned Over Reporting of Biomonitoring Results 625 2ACC Concerned Over Reporting of Biomonitoring Results 625 3
...SS WIRE)--Jul 2, 2007 - ViaCell, Inc.,(NASDAQ: VIA...d,Chief Executive Officer of ViaCell, will present...pipeline at the C.E. Unterberg,Towbin Emerging Gr... 2007 at 3:00 p.m. at the Mandarin Oriental Hotel ...ntation will be available on,the Investor Informat...
...0, 2007 /PRNewswire-FirstCall/ - Bradmer,Pharmaceu... to the,development and commercialization of cance...lished by an independent team in,Basel, Switzerlan...get for the development of new treatments for glio...ified that the loss of NOTCH2 gene,positively pred...
Other Medicine Technology:Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 2Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 3Molecular Target of Bradmer's Neuradiab Further Validated by,Independent Findings 4
...ists steerable guidewires across difficult lesions...eter offers a low profile (3F-4F) and is compatibl... crossing difficult occlusions. Once the occlusio...guidewire position and an angioplasty balloon is d...
Introduced more than 30 years ago by Dr. Thomas J. Fogarty, these embolectomy catheters are indicated for the removal of fresh, soft emboli and thrombi from vessels in the arterial system.
The new XVG catheter is our highest power thrombectomy catheter designed for accessing distal anatomy. Utilizing proprietary Cross-Stream water jet technology, the XVG catheter removes thrombus quick
...copic navigation system that tracks multiple intra...d Wittkampf, Ph.D., and is being developed by Surg...,The LocaLisa system uses three skin electrode p...art to track catheters. Using a reference electrod...
Medicine Products: